Department of Nursing and Midwifery Science, Centre For Research and Innovation in Care (CRIC), Nurse and Pharmaceutical Care (NuPhaC), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Department of Healthcare, Thomas More University College, 2500 Lier, Belgium.
Int J Environ Res Public Health. 2022 Dec 13;19(24):16715. doi: 10.3390/ijerph192416715.
An intervention, SelfMED, was introduced to facilitate patient self-management of medication during hospitalization. This study aimed to evaluate the feasibility and safety of the SelfMED intervention. All patients in a cardiology ward in a Belgian regional hospital were assessed for suitability for inclusion, applying an evidence-based stepped assessment tool. Patients eligible for medication self-management and willing to participate were included in the study (i.e., consecutive sampling). Patients who self-managed their medication were closely monitored by nurses. The feasibility of medication self-management was evaluated by implementation and completion rates and the opinions of cardiologists. Safety was evaluated by medication administration errors and errors in patients' registration of intake. Of 159 patients assessed for eligibility to self-manage medication in-hospital, 61 were included. A total of 367 medicines were self-managed. Pill counts showed 3 administration errors (0.8%), and on 6 occasions (1.7%) the patient's registration of the intake was incorrect. SelfMED was deemed feasible within the hospital ward. In cardiologists' opinions, SelfMED requires substantial time investment. In summary, SelfMED facilitated patient medication self-management in-hospital. As an essential step in the preparation for a full trial, this study showed it is feasible and safe to implement the intervention and identified some possibilities for refinement.
一项名为 SelfMED 的干预措施被引入，以促进患者在住院期间自我管理药物。本研究旨在评估 SelfMED 干预措施的可行性和安全性。对比利时一家地区医院心内科病房的所有患者进行了评估，以确定其是否适合纳入，应用了基于证据的逐步评估工具。符合药物自我管理条件且愿意参与的患者被纳入研究（即连续抽样）。由护士密切监测自行管理药物的患者。通过实施和完成率以及心脏病专家的意见评估药物自我管理的可行性。通过药物管理错误和患者用药登记错误评估安全性。在评估了 159 名适合自我管理院内用药的患者中，有 61 名符合条件。共有 367 种药物被自我管理。药物计数显示有 3 次给药错误（0.8%），有 6 次（1.7%）患者的用药登记不正确。SelfMED 在医院病房内被认为是可行的。在心脏病专家看来，SelfMED 需要大量的时间投入。总的来说，SelfMED 促进了患者在院期间的药物自我管理。作为全面试验准备的重要步骤，本研究表明实施该干预措施是可行且安全的，并确定了一些改进的可能性。
